FQHC Look-Alike vs. Section 330 Grant: Which Path Fits Your Clinic in 2026

Two routes to FQHC status carry different timelines, funding ceilings, and compliance burdens — here is how to choose the right one.

By Anthony Pinto · Founder, Triad Health Engine · Published 2026-06-23 · 11-min read

The short answer — Clinics pursuing FQHC status in 2026 face a binary choice: apply for a HRSA Section 330 New Access Point (NAP) grant when a funding opportunity is open, or pursue FQHC Look-Alike (LAL) designation through the year-round HRSA Electronic Handbook (EHB) process. The Section 330 path can yield $650,000 to $2M+ in direct federal grant funding annually but requires waiting for a competitive Notice of Funding Opportunity (NOFO), scoring well against dozens of applicants, and absorbing an 18-to-24-month award cycle. The Look-Alike path delivers no direct grant dollars but activates Medicare and Medicaid Prospective Payment System (PPS) rates, 340B drug pricing eligibility, malpractice coverage under FTCA (if deemed), and enhanced CHIP/CHC matching within 6 to 12 months of a complete application. For most independent RHCs, Federally Qualified Health Center Look-Alikes are the faster path to per-visit rate stability. For community coalitions launching de novo primary care in a Health Professional Shortage Area, the Section 330 grant is worth the wait. This post walks both tracks with timelines, cost-benefit math, and a side-by-side decision matrix.